GSTM1 and anemia: Most of the patients were anemic (99%), with one-quarter (26%) suffering from mild-to-moderate anemia (hemoglobin (Hb) above 10 g/dL) and the remaining three-quarters (74%) suffering from severe anemia (Hb below 10 g/dL).